Literature DB >> 11097717

Gastric Cancer.

.   

Abstract

The best treatment for gastric cancer remains early detection and prompt surgical removal. Currently, the majority of gastric carcinomas diagnosed in western centers are late-stage tumors with poor prognoses. Endoscopic ultrasound and diagnostic laparoscopy aid our ability to accurately stage patients with gastric cancers, and may prevent unnecessary laparotomies in asymptomatic patients. While extended lymphadenectomy is the standard approach in Japanese centers, the utility of this procedure in improving long-term survival has yet to be proved in prospective, randomized trials. Accurate staging of patients preoperatively and selected multidisciplinary approaches to individual patients may eventually lead to improvements in survival for patients with gastric cancer.

Entities:  

Year:  1999        PMID： 11097717     DOI： 10.1007/s11938-999-0056-8

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN： 1092-8472


  30 in total

1.  Improvement in treatment results of gastric cancer with surgery and chemotherapy: experience of 9,700 cases in the Cancer Institute Hospital, Tokyo.

Authors:  T Nakajima; M Nishi; T Kajitani
Journal:  Semin Surg Oncol       Date:  1991 Nov-Dec

2.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma.

Authors:  D M Dent; M V Madden; S K Price
Journal:  Br J Surg       Date:  1988-02       Impact factor: 6.939

3.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

4.  Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach.

Authors:  L E Harrison; M S Karpeh; M F Brennan
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

5.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

6.  A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer.

Authors:  J E Krook; M J O'Connell; H S Wieand; R W Beart; J E Leigh; J W Kugler; J F Foley; D M Pfeifle; D I Twito
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

7.  Cancer of the stomach. A patient care study by the American College of Surgeons.

Authors:  H J Wanebo; B J Kennedy; J Chmiel; G Steele; D Winchester; R Osteen
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

8.  Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.

Authors:  J A Ajani; D M Ota; J M Jessup; F C Ames; C McBride; A Boddie; B Levin; D E Jackson; M Roh; D Hohn
Journal:  Cancer       Date:  1991-10-01       Impact factor: 6.860

9.  Endoscopic Nd:YAG treatment of superficial gastric carcinoma: experience in 18 Western inoperable patients.

Authors:  A Sibille; C Descamps; P Jonard; C Dive; P Warzeé; M Schapira; A Geubel
Journal:  Gastrointest Endosc       Date:  1995-10       Impact factor: 9.427

10.  Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach.

Authors:  S Ohno; S Tomisaki; H Oiwa; Y Sakaguchi; Y Ichiyoshi; Y Maehara; K Sugimachi
Journal:  J Am Coll Surg       Date:  1995-05       Impact factor: 6.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.